Korean J Parasitol.  2000 Jun;38(2):75-84. 10.3347/kjp.2000.38.2.75.

Persisting antibody reaction in paragonimiasis after praziquantel treatment is elicited mainly by egg antigens

Affiliations
  • 1Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea. seungyl@med.skku.ac.kr

Abstract

Antibody responses in serum and cerebrospinal fluid (CSF) samples from patients with active and chronic paragonimiasis and in sera from patients on whom follow-up studies were done after praziquantel treatment were analyzed using antigens of Paragonimus westermani prepared from eggs, metacercariae, juveniles of 4- and 7-week old, adult worms and recombinant protein of 28 kDa cruzipain-like cysteine protease (rPw28CCP). The patient sera/CSFs of active and chronic paragonimiasis revealed strong antibody reactions against the crude extracts of 4- and 7-week old juveniles as well as against those from egg and adult. rPw28CCP also showed specific reaction to the sera with active paragonimiasis. After the treatment, levels of specific antibodies in the sera gradually decreased to negative range in most patients. In some cases with persisting high antibody levels, however, the reactions at 27 kDa egg protein were sustained throughout the observation period of 34 months. The reactions at 35 and 32 kDa in adult extract and rPw28CCP disappeared rapidly after the treatment. Persistent antibody reactions even after successful treatment are provoked by continuous antigenic challenge from eggs which were not resolved by treatment.


MeSH Terms

Animal
Anthelmintics/therapeutic use*
Antibodies, Helminth/blood*
Antigens, Helminth/immunology*
Human
Ovum/immunology
Paragonimiasis/parasitology
Paragonimiasis/immunology
Paragonimiasis/drug therapy*
Paragonimus/physiology
Paragonimus/immunology*
Praziquantel/therapeutic use*
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr